CN105381289A - Pharmaceutical composition for treating abnormal menstruation - Google Patents
Pharmaceutical composition for treating abnormal menstruation Download PDFInfo
- Publication number
- CN105381289A CN105381289A CN201510890337.9A CN201510890337A CN105381289A CN 105381289 A CN105381289 A CN 105381289A CN 201510890337 A CN201510890337 A CN 201510890337A CN 105381289 A CN105381289 A CN 105381289A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- rhizoma
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 32
- 230000005906 menstruation Effects 0.000 title abstract description 10
- 230000002159 abnormal effect Effects 0.000 title abstract description 5
- 210000000582 semen Anatomy 0.000 claims abstract description 22
- 244000207032 American speedwell Species 0.000 claims abstract description 21
- 239000008589 Cortex Fraxini Substances 0.000 claims abstract description 21
- 208000019255 Menstrual disease Diseases 0.000 claims description 34
- 239000003814 drug Substances 0.000 claims description 26
- 229940079593 drug Drugs 0.000 claims description 21
- 241000628997 Flos Species 0.000 claims description 20
- 241001250596 Pleione Species 0.000 claims description 20
- 239000009806 pulsatillae Substances 0.000 claims description 20
- 239000002689 soil Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 3
- 238000007796 conventional method Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000007919 dispersible tablet Substances 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 5
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 241000031023 Amana edulis Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 abstract 1
- 235000017491 Bambusa tulda Nutrition 0.000 abstract 1
- 241000425308 Begonia fimbristipula Species 0.000 abstract 1
- 244000025254 Cannabis sativa Species 0.000 abstract 1
- 241000518307 Cassytha Species 0.000 abstract 1
- 241000252804 Cinnamomum insularimontanum Species 0.000 abstract 1
- 241000735527 Eupatorium Species 0.000 abstract 1
- 241001598107 Imperata Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 244000280244 Luffa acutangula Species 0.000 abstract 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 abstract 1
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 abstract 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 abstract 1
- 235000011613 Pinus brutia Nutrition 0.000 abstract 1
- 241000018646 Pinus brutia Species 0.000 abstract 1
- 244000292697 Polygonum aviculare Species 0.000 abstract 1
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 241000206469 Pulsatilla Species 0.000 abstract 1
- 244000193032 Rheum rhaponticum Species 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 241000220261 Sinapis Species 0.000 abstract 1
- 241001530121 Trollius Species 0.000 abstract 1
- 241000877996 Vallisneria natans Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 239000011425 bamboo Substances 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 230000027758 ovulation cycle Effects 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 6
- 239000012467 final product Substances 0.000 description 5
- 230000003821 menstrual periods Effects 0.000 description 5
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 208000007106 menorrhagia Diseases 0.000 description 4
- 230000002175 menstrual effect Effects 0.000 description 4
- 230000001476 alcoholic effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 208000019022 Mood disease Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000005574 cross-species transmission Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a pharmaceutical composition for treating abnormal menstruation. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 15 to 35 parts of Chinese angelica, 10 to 30 parts of semen cuscutae, 10 to 20 parts of ligusticum wallichii, 10 to 20 parts of loofah sponge, 15 to 30 parts of lalang grass rhizome, 10 to 20 parts of bark of Japanese cinnamon, 5 to 20 parts of rheum franzenbachii, 5 to 15 parts of polygonum aviculare, 10 to 20 parts of red sage root, 5 to 15 parts of purslane speedwell, 5 to 15 parts of bitter bamboo leaf, 5 to 15 parts of eupatorium fortune, 10 to 30 parts of edible tulip, 10 to 20 parts of herb of filliform cassytha, 10 to 20 parts of root of Chinese pulsatilla, 5 to 15 parts of begonia fimbristipula, 5 to 10 parts of root of kudzu vine, 5 to 15 parts of cortex fraxini, 10 to 20 parts of globeflower, 10 to 20 parts of semen sinapis, 5 to 15 parts of vallisneria natans, and 5 to 15 parts of pine root. The pharmaceutical composition has the functions of activating blood, regulating menstruation, removing stasis, dissipating binds, nourishing and regulating blood, tonifying middle jiao, and boosting qi, can be used to treat abnormal menstruation and dysmenorrheal caused by various reasons, and does not have any side or toxic effect, and the curative effect is prominent.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, in particular to a kind of pharmaceutical composition for the treatment of menoxenia.
Background technology
Menstruation, leucorrhea are the important symbols of woman's health.Menstruation refers to that womb inner membrance is under the effect of ovarian hormone, generating period comes off and with hemorrhage, the twice month interval time through first day was 28-30 days, shift to an earlier date or delay 7 days and still belong to normal, be abnormal more than 7 days, each amount of menstrual bleeding is about 50-80ml, menorrhagia or very fewly all belong to abnormal.A lot of reasons can cause menoxenia, as endocrine disturbance or self some disease, also have some bad habits as irregular in the daily schedule, greedy cool, overwork, excessively go on a diet, have a liking for tobacco and wine, mood disorders, pressure is large, takes some drugs and also can cause menoxenia.According to the display of Ministry of Public Health investigation statistics, China's gynaecopathia sickness rate is up to 75%, and wherein menoxenia, dysmenorrhea patient account for 50%.
Current doctor trained in Western medicine is just treated for symptom, and after treatment, easy recurrent exerbation, brings very large misery to patient.The traditional Chinese medical science have accumulated rich experience in this respect.The traditional Chinese medical science thinks etiology and pathogenesis mainly damaged by excess of seven emotions or the diseases caused by exogenous pathogenic factor six climate exopathogens of menoxenia or congenital deficiency of kidney-QI, and fecund is tired, and overstrain, makes visceral-qi impaired, and kidney function of liver and spleen is not normal, qi and blood disorder, and causing wantonly two arteries and veins of punching and damage and fall ill, is many with qi depression to blood stasis.Patient's element is worried depression more, and gas is not declared and reached, and blood is the stagnation of QI, and retardance punching is appointed, and menses run smooth, and the sea of blood can not spill-over on time, sends out as menoxenia and dysmenorrhea.Eliminate the cause of disease, ask this opinion to control, regulating YIN and YANG balances, and recovering body physiological function, is the cardinal principle of regulating menstruation.
Summary of the invention
The invention provides a kind of pharmaceutical composition for the treatment of menoxenia, based on the dialectical prescription of tcm theory, there is promoting blood flow to regulate menstruation, eliminating stasis and resolving masses, enrich blood and adjust effect of blood, invigorating the spleen and replenishing QI, be used for the treatment of menoxenia that a variety of causes causes, dysmenorrhea, have no side effect, therapeutic effect is remarkable.
Concrete, one aspect of the present invention provides a kind of pharmaceutical composition for the treatment of menoxenia, be made up of the crude drug of following weight portion: Radix Angelicae Sinensis 15-35 part, Semen Cuscutae 10-30 part, Rhizoma Chuanxiong 10-20 part, Retinervus Luffae Fructus 10-20 part, Rhizoma Imperatae 15-30 part, soil Cortex cinnamomi japonici (Ramulus Cinnamomi) 10-20 part, Radix et Rhizoma Rhei Franzenbachii 5-20 part, Herba Polygoni Avicularis 5-15 part, Radix Salviae Miltiorrhizae 10-20 part, purslane speedwell Herba 5-15 part, Folium Pleioblasti 5-15 part, Herba Eupatorii 5-15 part, Pseudobulbus Cremastrae Seu Pleiones 10-30 part, Herba Casythae Filiformis 10-20 part, Radix Pulsatillae 10-20 part, Rhizoma Begoniae Fimbristipulatae 5-15 part, Radix Puerariae 5-10 part, Cortex Fraxini 5-15 part, Flos Trollii 10-20 part, Semen Sinapis Albae 10-20 part, Herba vallisneriae Spiralis 5-15 part, Radix Pini massonianae 5-15 part.
In the embodiment that the present invention one is concrete, a kind of pharmaceutical composition for the treatment of menoxenia is made up of the crude drug of following weight portion: Radix Angelicae Sinensis 15-25 part, Semen Cuscutae 10-20 part, Rhizoma Chuanxiong 10-20 part, Retinervus Luffae Fructus 10-20 part, Rhizoma Imperatae 15-25 part, soil Cortex cinnamomi japonici (Ramulus Cinnamomi) 10-15 part, Radix et Rhizoma Rhei Franzenbachii 5-15 part, Herba Polygoni Avicularis 5-10 part, Radix Salviae Miltiorrhizae 10-15 part, purslane speedwell Herba 5-10 part, Folium Pleioblasti 5-10 part, Herba Eupatorii 5-15 part, Pseudobulbus Cremastrae Seu Pleiones 10-20 part, Herba Casythae Filiformis 10-15 part, Radix Pulsatillae 10-15 part, Rhizoma Begoniae Fimbristipulatae 5-10 part, Radix Puerariae 5-10 part, Cortex Fraxini 5-15 part, Flos Trollii 10-15 part, Semen Sinapis Albae 10-15 part, Herba vallisneriae Spiralis 5-10 part, Radix Pini massonianae 5-10 part.
In the embodiment that the present invention one is concrete, a kind of pharmaceutical composition for the treatment of menoxenia is made up of the crude drug of following weight portion: Radix Angelicae Sinensis 20-35 part, Semen Cuscutae 20-30 part, Rhizoma Chuanxiong 15-20 part, Retinervus Luffae Fructus 15-20 part, Rhizoma Imperatae 20-30 part, soil Cortex cinnamomi japonici (Ramulus Cinnamomi) 15-20 part, Radix et Rhizoma Rhei Franzenbachii 10-20 part, Herba Polygoni Avicularis 10-15 part, Radix Salviae Miltiorrhizae 15-20 part, purslane speedwell Herba 10-15 part, Folium Pleioblasti 10-15 part, Herba Eupatorii 10-15 part, Pseudobulbus Cremastrae Seu Pleiones 20-30 part, Herba Casythae Filiformis 15-20 part, Radix Pulsatillae 15-20 part, Rhizoma Begoniae Fimbristipulatae 10-15 part, Radix Puerariae 5-10 part, Cortex Fraxini 10-15 part, Flos Trollii 15-20 part, Semen Sinapis Albae 15-20 part, Herba vallisneriae Spiralis 10-15 part, Radix Pini massonianae 10-15 part.
In the embodiment that the present invention one is concrete, a kind of pharmaceutical composition for the treatment of menoxenia is made up of the crude drug of following weight portion: Radix Angelicae Sinensis 35 parts, Semen Cuscutae 30 parts, Rhizoma Chuanxiong 20 parts, Retinervus Luffae Fructus 20 parts, Rhizoma Imperatae 30 parts, soil 20 parts, Cortex cinnamomi japonici (Ramulus Cinnamomi), Radix et Rhizoma Rhei Franzenbachii 20 Fen ， Herba Polygoni Avicularis 15 parts, Radix Salviae Miltiorrhizae 20 parts, purslane speedwell Herba 15 parts, Folium Pleioblasti 15 parts, Herba Eupatorii 15 parts, Pseudobulbus Cremastrae Seu Pleiones 30 parts, Herba Casythae Filiformis 20 parts, the Radix Pulsatillae 20 parts, Rhizoma Begoniae Fimbristipulatae 15 parts, Radix Puerariae 10 parts, Cortex Fraxini 15 parts, Flos Trollii 20 parts, Semen Sinapis Albae 20 parts, Herba vallisneriae Spiralis 15 parts, Radix Pini massonianae 15 parts.
In the embodiment that the present invention one is concrete, a kind of pharmaceutical composition for the treatment of menoxenia is made up of the crude drug of following weight portion: Radix Angelicae Sinensis 15 parts, Semen Cuscutae 10 parts, Rhizoma Chuanxiong 10 parts, Retinervus Luffae Fructus 10 parts, Rhizoma Imperatae 15 parts, 10 parts, native Cortex cinnamomi japonici (Ramulus Cinnamomi), Radix et Rhizoma Rhei Franzenbachii 5 parts of Herba Polygoni Avicularis 5 parts, Radix Salviae Miltiorrhizae 10 parts, purslane speedwell Herba 5 parts, Folium Pleioblasti 5 parts, Herba Eupatorii 5 parts, Pseudobulbus Cremastrae Seu Pleiones 10 parts, Herba Casythae Filiformis 10 parts, the Radix Pulsatillae 10 parts, Rhizoma Begoniae Fimbristipulatae 5 parts, Radix Puerariae 5 parts, Cortex Fraxini 5 parts, Flos Trollii 10 parts, Semen Sinapis Albae 10 parts, Herba vallisneriae Spiralis 5 parts, Radix Pini massonianae 5 parts.
In the embodiment that the present invention one is concrete, a kind of pharmaceutical composition for the treatment of menoxenia is made up of the crude drug of following weight portion: Radix Angelicae Sinensis 35 parts, Semen Cuscutae 10 parts, Rhizoma Chuanxiong 20 parts, Retinervus Luffae Fructus 10 parts, Rhizoma Imperatae 30 parts, soil 10 parts, Cortex cinnamomi japonici (Ramulus Cinnamomi), Radix et Rhizoma Rhei Franzenbachii 20 Fen ， Herba Polygoni Avicularis 5 parts, Radix Salviae Miltiorrhizae 20 parts, purslane speedwell Herba 5 parts, Folium Pleioblasti 15 parts, Herba Eupatorii 5 parts, Pseudobulbus Cremastrae Seu Pleiones 30 parts, Herba Casythae Filiformis 10 parts, the Radix Pulsatillae 20 parts, Rhizoma Begoniae Fimbristipulatae 5 parts, Radix Puerariae 10 parts, Cortex Fraxini 5 parts, Flos Trollii 20 parts, Semen Sinapis Albae 10 parts, Herba vallisneriae Spiralis 15 parts, Radix Pini massonianae 5 parts.
In the embodiment that the present invention one is concrete, a kind of pharmaceutical composition for the treatment of menoxenia is made up of the crude drug of following weight portion: Radix Angelicae Sinensis 25 parts, Semen Cuscutae 20 parts, Rhizoma Chuanxiong 15 parts, Retinervus Luffae Fructus 15 parts, Rhizoma Imperatae 23 parts, soil 14 parts, Cortex cinnamomi japonici (Ramulus Cinnamomi), Radix et Rhizoma Rhei Franzenbachii 13 Fen ， Herba Polygoni Avicularis 10 parts, Radix Salviae Miltiorrhizae 15 parts, purslane speedwell Herba 10 parts, Folium Pleioblasti 10 parts, Herba Eupatorii 10 parts, Pseudobulbus Cremastrae Seu Pleiones 20 parts, Herba Casythae Filiformis 15 parts, the Radix Pulsatillae 15 parts, Rhizoma Begoniae Fimbristipulatae 10 parts, Radix Puerariae 8 parts, Cortex Fraxini 10 parts, Flos Trollii 15 parts, Semen Sinapis Albae 15 parts, Herba vallisneriae Spiralis 10 parts, Radix Pini massonianae 12 parts.
The present invention provides a kind of preparation method for the treatment of the pharmaceutical composition of menoxenia on the other hand, and it is characterized in that, the preparation method of this pharmaceutical composition comprises the following steps:
(1) Radix Angelicae Sinensis, Semen Cuscutae, Rhizoma Imperatae, Radix et Rhizoma Rhei Franzenbachii, Radix Salviae Miltiorrhizae, Folium Pleioblasti, Pseudobulbus Cremastrae Seu Pleiones, the Radix Pulsatillae, Radix Puerariae, Flos Trollii, Herba vallisneriae Spiralis, Radix Pini massonianae are added soak by water 2-3 time accounting for gross weight 8-15 times amount, each 1.5-2 hour, collecting decoction, add the aqueous solution that step (1) obtains again, filter, relative density when filtrate is concentrated into 80 DEG C is the extractum (I) of 1.15-1.25;
(2) Rhizoma Chuanxiong, Retinervus Luffae Fructus, native Cortex cinnamomi japonici (Ramulus Cinnamomi), Herba Polygoni Avicularis, purslane speedwell Herba, Herba Eupatorii, Herba Casythae Filiformis, Rhizoma Begoniae Fimbristipulatae, Cortex Fraxini, Semen Sinapis Albae are added account for gross weight 8-15 times amount 85% alcoholic solution in extract 2-3 time, each 2-3 hour, filter, merging filtrate, placement is spent the night, reclaim ethanol, relative density when filtrate being concentrated into 60 DEG C is the extractum (II) of 1.15-1.25;
(3) in step (1), the mixing of (2) gained extractum, dry, stir, to obtain final product.
In a concrete embodiment of the present invention, wherein add the soak by water 3 times accounting for gross weight 10 times amount in step (1), each 1.5 hours; Account in step (2) in the alcoholic solution of 85% of gross weight 10 times amount and extract 2 times, each 3 hours.
The pharmaceutical composition for the treatment of menoxenia of the present invention, also can prepare according to the conventional method of the field of Chinese medicines, comprises soak by water, by each crude drug pulverize etc.The conventional method of Chinese medicine preparation can be adopted to be prepared into any traditional oral preparation.Described oral formulations is capsule, pill, powder, tablet, dispersible tablet, granule.
Pharmaceutical composition of the present invention, based on the dialectical prescription of tcm theory, based on the dialectical prescription of tcm theory, there is promoting blood flow to regulate menstruation, eliminating stasis and resolving masses, enrich blood and adjust effect of blood, invigorating the spleen and replenishing QI, be used for the treatment of menoxenia that a variety of causes causes, dysmenorrhea, have no side effect, therapeutic effect is remarkable.
Detailed description of the invention
Embodiment 1:
The pharmaceutical composition for the treatment of menoxenia is made up of the crude drug of following weight portion: a Radix Angelicae Sinensis 35g, Semen Cuscutae 30g, Rhizoma Chuanxiong 20g, Retinervus Luffae Fructus 20g, Rhizoma Imperatae 30g, native Cortex cinnamomi japonici (Ramulus Cinnamomi) 20g, Radix et Rhizoma Rhei Franzenbachii 20g ， Herba Polygoni Avicularis 15g, Radix Salviae Miltiorrhizae 20g, purslane speedwell Herba 15g, Folium Pleioblasti 15g, Herba Eupatorii 15g, Pseudobulbus Cremastrae Seu Pleiones 30g, Herba Casythae Filiformis 20g, Radix Pulsatillae 20g, Rhizoma Begoniae Fimbristipulatae 15g, Radix Puerariae 10g, Cortex Fraxini 15g, Flos Trollii 20g, Semen Sinapis Albae 20g, Herba vallisneriae Spiralis 15g, Radix Pini massonianae 15g;
Each crude drug is dry at 45 DEG C, be cooled to room temperature, pulverize state, and mix homogeneously, load snap fit capsule, to obtain final product.
Embodiment 2:
The pharmaceutical composition for the treatment of menoxenia is made up of the crude drug of following weight portion: a Radix Angelicae Sinensis 15g, Semen Cuscutae 10g, Rhizoma Chuanxiong 10g, Retinervus Luffae Fructus 10g, Rhizoma Imperatae 15g, native Cortex cinnamomi japonici (Ramulus Cinnamomi) 10g, Radix et Rhizoma Rhei Franzenbachii 5g ， Herba Polygoni Avicularis 5g, Radix Salviae Miltiorrhizae 10g, purslane speedwell Herba 5g, Folium Pleioblasti 5g, Herba Eupatorii 5g, Pseudobulbus Cremastrae Seu Pleiones 10g, Herba Casythae Filiformis 10g, Radix Pulsatillae 10g, Rhizoma Begoniae Fimbristipulatae 5g, Radix Puerariae 5g, Cortex Fraxini 5g, Flos Trollii 10g, Semen Sinapis Albae 10g, Herba vallisneriae Spiralis 5g, Radix Pini massonianae 5g;
Take said medicine by formula ratio, be added to the water, boil, slow fire boiling 30 minutes, filter, filtering residue adds water again, slow fire boiling 30 minutes, merge twice medicinal liquid, to obtain final product.
Embodiment 3:
The pharmaceutical composition for the treatment of menoxenia is made up of the crude drug of following weight portion: a Radix Angelicae Sinensis 35g, Semen Cuscutae 10g, Rhizoma Chuanxiong 20g, Retinervus Luffae Fructus 10g, Rhizoma Imperatae 30g, native Cortex cinnamomi japonici (Ramulus Cinnamomi) 10g, Radix et Rhizoma Rhei Franzenbachii 20g ， Herba Polygoni Avicularis 5g, Radix Salviae Miltiorrhizae 20g, purslane speedwell Herba 5g, Folium Pleioblasti 15g, Herba Eupatorii 5g, Pseudobulbus Cremastrae Seu Pleiones 30g, Herba Casythae Filiformis 10g, Radix Pulsatillae 20g, Rhizoma Begoniae Fimbristipulatae 5g, Radix Puerariae 10g, Cortex Fraxini 5g, Flos Trollii 20g, Semen Sinapis Albae 10g, Herba vallisneriae Spiralis 15g, Radix Pini massonianae 5g;
Preparation method comprises the following steps:
(1) Radix Angelicae Sinensis, Semen Cuscutae, Rhizoma Imperatae, Radix et Rhizoma Rhei Franzenbachii, Radix Salviae Miltiorrhizae, Folium Pleioblasti, Pseudobulbus Cremastrae Seu Pleiones, the Radix Pulsatillae, Radix Puerariae, Flos Trollii, Herba vallisneriae Spiralis, Radix Pini massonianae are added the soak by water 3 times accounting for gross weight 10 times amount, each 2 hours, collecting decoction, add the aqueous solution that step (1) obtains again, filter, relative density when filtrate is concentrated into 80 DEG C is the extractum (I) of 1.15-1.25;
(2) Rhizoma Chuanxiong, Retinervus Luffae Fructus, native Cortex cinnamomi japonici (Ramulus Cinnamomi), Herba Polygoni Avicularis, purslane speedwell Herba, Herba Eupatorii, Herba Casythae Filiformis, Rhizoma Begoniae Fimbristipulatae, Cortex Fraxini, Semen Sinapis Albae are added account for gross weight 10 times amount 85% alcoholic solution in extract 3 times, each 3 hours, filter, merging filtrate, placement is spent the night, reclaim ethanol, relative density when filtrate being concentrated into 60 DEG C is the extractum (II) of 1.15-1.25;
(3) in step (1), the mixing of (2) gained extractum, dry, stir, incapsulate and get final product.
Embodiment 4:
The pharmaceutical composition for the treatment of menoxenia is made up of the crude drug of following weight portion: a Radix Angelicae Sinensis 25g, Semen Cuscutae 20g, Rhizoma Chuanxiong 15g, Retinervus Luffae Fructus 15g, Rhizoma Imperatae 23g, native Cortex cinnamomi japonici (Ramulus Cinnamomi) 14g, Radix et Rhizoma Rhei Franzenbachii 13g ， Herba Polygoni Avicularis 10g, Radix Salviae Miltiorrhizae 15g, purslane speedwell Herba 10g, Folium Pleioblasti 10g, Herba Eupatorii 10g, Pseudobulbus Cremastrae Seu Pleiones 20g, Herba Casythae Filiformis 15g, Radix Pulsatillae 15g, Rhizoma Begoniae Fimbristipulatae 10g, Radix Puerariae 8g, Cortex Fraxini 10g, Flos Trollii 15g, Semen Sinapis Albae 15g, Herba vallisneriae Spiralis 10g, Radix Pini massonianae 12g;
Take said medicine by formula ratio, be added to the water, boil, slow fire boiling 30 minutes, filter, filtering residue adds water again, slow fire boiling 30 minutes, merge twice medicinal liquid, to obtain final product.
Embodiment 5: clinical data
1, physical data
Selection of clinical menoxenia patient 100 example.Diagnostic criteria: (1) preceeded menorrhea: menstrual cycle shifts to an earlier date more than 7 days, the normal continuous appearance of menstrual blood volume two above persons of menstrual cycle; (2) delayed menstrual cycle: menstrual cycle delays more than 7 days, the normal continuous appearance of menstrual blood volume two above persons of menstrual cycle; (3) irregular menstrual period: during menstruation or in advance, time or delay more than 7 days, but be no more than two weeks, menstrual blood volume is normal, continuously appearance two above persons of menstrual cycle; (4) menorrhagia, menstrual cycle is normal, and through amount showed increased more in the past, or through amount more than 100ml, there are two above persons of menstrual cycle continuously; (5) hypomenorrhea, menstrual cycle is normal, and through measuring obvious minimizing, or shorten less than two days in surprise, be also less than through amount normal, occur two above persons of menstrual cycle continuously; (6) menostaxis, menstrual cycle and normal through measuring, the time of passing through more than more than 7 days, but is less than two weeks, occurs two above persons of menstrual cycle continuously.
2, Therapeutic Method
Adopt oral liquid prepared by embodiment 2, every day is early, middle and late respectively takes 10ml to patient, within 15 days, is a course for the treatment of, minimumly takes 3 courses for the treatment of.
3, curative effect determinate standard
(1) fully recover: treat rear menstrual cycle, through amount, recover normal menstrual period, other transference cures, drug withdrawal menstrual cycle does not recur.
(2) effective: after treatment, menstrual cycle recovers 28 ± 7 days, menorrhagia person is through amount than minimizing 1/3 or be less than 100ml before treatment, and within returning to menstrual period 7 days, other transference cures or alleviate, drug withdrawal menstrual cycle is without recurrence.
(3) effective: treat rear menstrual cycle, through amount, comparatively treat front improvement menstrual period, other symptoms alleviate before comparatively treating.
(4) invalid: treatment after menstrual cycle, through amount and menstrual period without improvement.
4, therapeutic outcome:
Result after 3 courses for the treatment of: clinical recovery 50 people; Effective 28 people; Effective 17 people; Invalid 5 people; The present invention is 95% to menoxenia effective percentage.
Claims (9)
1. treat the pharmaceutical composition of menoxenia for one kind, be made up of the crude drug of following weight portion: Radix Angelicae Sinensis 15-35 part, Semen Cuscutae 10-30 part, Rhizoma Chuanxiong 10-20 part, Retinervus Luffae Fructus 10-20 part, Rhizoma Imperatae 15-30 part, soil Cortex cinnamomi japonici (Ramulus Cinnamomi) 10-20 part, Radix et Rhizoma Rhei Franzenbachii 5-20 part, Herba Polygoni Avicularis 5-15 part, Radix Salviae Miltiorrhizae 10-20 part, purslane speedwell Herba 5-15 part, Folium Pleioblasti 5-15 part, Herba Eupatorii 5-15 part, Pseudobulbus Cremastrae Seu Pleiones 10-30 part, Herba Casythae Filiformis 10-20 part, Radix Pulsatillae 10-20 part, Rhizoma Begoniae Fimbristipulatae 5-15 part, Radix Puerariae 5-10 part, Cortex Fraxini 5-15 part, Flos Trollii 10-20 part, Semen Sinapis Albae 10-20 part, Herba vallisneriae Spiralis 5-15 part, Radix Pini massonianae 5-15 part.
2. a kind of pharmaceutical composition for the treatment of menoxenia according to claim 1, be made up of the crude drug of following weight portion: Radix Angelicae Sinensis 15-25 part, Semen Cuscutae 10-20 part, Rhizoma Chuanxiong 10-20 part, Retinervus Luffae Fructus 10-20 part, Rhizoma Imperatae 15-25 part, soil Cortex cinnamomi japonici (Ramulus Cinnamomi) 10-15 part, Radix et Rhizoma Rhei Franzenbachii 5-15 part, Herba Polygoni Avicularis 5-10 part, Radix Salviae Miltiorrhizae 10-15 part, purslane speedwell Herba 5-10 part, Folium Pleioblasti 5-10 part, Herba Eupatorii 5-15 part, Pseudobulbus Cremastrae Seu Pleiones 10-20 part, Herba Casythae Filiformis 10-15 part, Radix Pulsatillae 10-15 part, Rhizoma Begoniae Fimbristipulatae 5-10 part, Radix Puerariae 5-10 part, Cortex Fraxini 5-15 part, Flos Trollii 10-15 part, Semen Sinapis Albae 10-15 part, Herba vallisneriae Spiralis 5-10 part, Radix Pini massonianae 5-10 part.
3. a kind of pharmaceutical composition for the treatment of menoxenia according to claim 1, be made up of the crude drug of following weight portion: Radix Angelicae Sinensis 20-35 part, Semen Cuscutae 20-30 part, Rhizoma Chuanxiong 15-20 part, Retinervus Luffae Fructus 15-20 part, Rhizoma Imperatae 20-30 part, soil Cortex cinnamomi japonici (Ramulus Cinnamomi) 15-20 part, Radix et Rhizoma Rhei Franzenbachii 10-20 part, Herba Polygoni Avicularis 10-15 part, Radix Salviae Miltiorrhizae 15-20 part, purslane speedwell Herba 10-15 part, Folium Pleioblasti 10-15 part, Herba Eupatorii 10-15 part, Pseudobulbus Cremastrae Seu Pleiones 20-30 part, Herba Casythae Filiformis 15-20 part, Radix Pulsatillae 15-20 part, Rhizoma Begoniae Fimbristipulatae 10-15 part, Radix Puerariae 5-10 part, Cortex Fraxini 10-15 part, Flos Trollii 15-20 part, Semen Sinapis Albae 15-20 part, Herba vallisneriae Spiralis 10-15 part, Radix Pini massonianae 10-15 part.
4. a kind of pharmaceutical composition for the treatment of menoxenia according to claim 1, is made up of the crude drug of following weight portion: Radix Angelicae Sinensis 35 parts, Semen Cuscutae 30 parts, Rhizoma Chuanxiong 20 parts, Retinervus Luffae Fructus 20 parts, Rhizoma Imperatae 30 parts, 20 parts, native Cortex cinnamomi japonici (Ramulus Cinnamomi), Radix et Rhizoma Rhei Franzenbachii 20 parts of Herba Polygoni Avicularis 15 parts, Radix Salviae Miltiorrhizae 20 parts, purslane speedwell Herba 15 parts, Folium Pleioblasti 15 parts, Herba Eupatorii 15 parts, Pseudobulbus Cremastrae Seu Pleiones 30 parts, Herba Casythae Filiformis 20 parts, the Radix Pulsatillae 20 parts, Rhizoma Begoniae Fimbristipulatae 15 parts, Radix Puerariae 10 parts, Cortex Fraxini 15 parts, Flos Trollii 20 parts, Semen Sinapis Albae 20 parts, Herba vallisneriae Spiralis 15 parts, Radix Pini massonianae 15 parts.
5. a kind of pharmaceutical composition for the treatment of menoxenia according to claim 1, is made up of the crude drug of following weight portion: Radix Angelicae Sinensis 15 parts, Semen Cuscutae 10 parts, Rhizoma Chuanxiong 10 parts, Retinervus Luffae Fructus 10 parts, Rhizoma Imperatae 15 parts, 10 parts, native Cortex cinnamomi japonici (Ramulus Cinnamomi), Radix et Rhizoma Rhei Franzenbachii 5 parts of Herba Polygoni Avicularis 5 parts, Radix Salviae Miltiorrhizae 10 parts, purslane speedwell Herba 5 parts, Folium Pleioblasti 5 parts, Herba Eupatorii 5 parts, Pseudobulbus Cremastrae Seu Pleiones 10 parts, Herba Casythae Filiformis 10 parts, the Radix Pulsatillae 10 parts, Rhizoma Begoniae Fimbristipulatae 5 parts, Radix Puerariae 5 parts, Cortex Fraxini 5 parts, Flos Trollii 10 parts, Semen Sinapis Albae 10 parts, Herba vallisneriae Spiralis 5 parts, Radix Pini massonianae 5 parts.
6. a kind of pharmaceutical composition for the treatment of menoxenia according to claim 1, is made up of the crude drug of following weight portion: Radix Angelicae Sinensis 35 parts, Semen Cuscutae 10 parts, Rhizoma Chuanxiong 20 parts, Retinervus Luffae Fructus 10 parts, Rhizoma Imperatae 30 parts, 10 parts, native Cortex cinnamomi japonici (Ramulus Cinnamomi), Radix et Rhizoma Rhei Franzenbachii 20 parts of Herba Polygoni Avicularis 5 parts, Radix Salviae Miltiorrhizae 20 parts, purslane speedwell Herba 5 parts, Folium Pleioblasti 15 parts, Herba Eupatorii 5 parts, Pseudobulbus Cremastrae Seu Pleiones 30 parts, Herba Casythae Filiformis 10 parts, the Radix Pulsatillae 20 parts, Rhizoma Begoniae Fimbristipulatae 5 parts, Radix Puerariae 10 parts, Cortex Fraxini 5 parts, Flos Trollii 20 parts, Semen Sinapis Albae 10 parts, Herba vallisneriae Spiralis 15 parts, Radix Pini massonianae 5 parts.
7. a kind of pharmaceutical composition for the treatment of menoxenia according to claim 1, is made up of the crude drug of following weight portion: Radix Angelicae Sinensis 25 parts, Semen Cuscutae 20 parts, Rhizoma Chuanxiong 15 parts, Retinervus Luffae Fructus 15 parts, Rhizoma Imperatae 23 parts, 14 parts, native Cortex cinnamomi japonici (Ramulus Cinnamomi), Radix et Rhizoma Rhei Franzenbachii 13 parts of Herba Polygoni Avicularis 10 parts, Radix Salviae Miltiorrhizae 15 parts, purslane speedwell Herba 10 parts, Folium Pleioblasti 10 parts, Herba Eupatorii 10 parts, Pseudobulbus Cremastrae Seu Pleiones 20 parts, Herba Casythae Filiformis 15 parts, the Radix Pulsatillae 15 parts, Rhizoma Begoniae Fimbristipulatae 10 parts, Radix Puerariae 8 parts, Cortex Fraxini 10 parts, Flos Trollii 15 parts, Semen Sinapis Albae 15 parts, Herba vallisneriae Spiralis 10 parts, Radix Pini massonianae 12 parts.
8. a kind of pharmaceutical composition for the treatment of menoxenia described in claim 1-7, is characterized in that, adopts the conventional method of Chinese medicine preparation to be prepared into any traditional oral preparation.
9. a kind of pharmaceutical composition for the treatment of menoxenia according to claim 8, is characterized in that, described oral formulations is capsule, pill, powder, tablet, granule, dispersible tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510890337.9A CN105381289A (en) | 2015-12-04 | 2015-12-04 | Pharmaceutical composition for treating abnormal menstruation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510890337.9A CN105381289A (en) | 2015-12-04 | 2015-12-04 | Pharmaceutical composition for treating abnormal menstruation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105381289A true CN105381289A (en) | 2016-03-09 |
Family
ID=55414464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510890337.9A Pending CN105381289A (en) | 2015-12-04 | 2015-12-04 | Pharmaceutical composition for treating abnormal menstruation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105381289A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105853686A (en) * | 2016-05-06 | 2016-08-17 | 木长俊 | Traditional Chinese medicine for treating delayed menorrhea caused by premature ovarian failure |
| CN105902780A (en) * | 2016-05-06 | 2016-08-31 | 木长俊 | Traditional Chinese medicine for treating delayed menstrual cycle caused by PCOS (Polycystic Ovarian Syndrome) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104784279A (en) * | 2015-05-16 | 2015-07-22 | 朱蕾 | Traditional Chinese medicine composition for treating irregular menstruation |
-
2015
- 2015-12-04 CN CN201510890337.9A patent/CN105381289A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104784279A (en) * | 2015-05-16 | 2015-07-22 | 朱蕾 | Traditional Chinese medicine composition for treating irregular menstruation |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105853686A (en) * | 2016-05-06 | 2016-08-17 | 木长俊 | Traditional Chinese medicine for treating delayed menorrhea caused by premature ovarian failure |
| CN105902780A (en) * | 2016-05-06 | 2016-08-31 | 木长俊 | Traditional Chinese medicine for treating delayed menstrual cycle caused by PCOS (Polycystic Ovarian Syndrome) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102302563B (en) | Chinese medicinal composition for treating chronic kidney failure and preparation method thereof | |
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN104587441A (en) | Cardiovascular disease regulating traditional Chinese medicine composition and preparation method thereof | |
| CN102670961B (en) | Traditional Chinese medicine for treating middle and old aged habitual constipation | |
| CN101502588B (en) | Composition for beauty treatment and removing blain and method for preparing the same | |
| CN104689232A (en) | Traditional Chinese medicine composition for adjusting cardiovascular and cerebrovascular diseases | |
| CN103223118B (en) | Traditional Chinese medicine composition for treating facial paralysis | |
| CN103055116B (en) | Traditional Chinese medicine composition for treating acnes | |
| CN102225100A (en) | Chinese medicinal formulation for treating cardiovascular and cerebrovascular diseases and preparation process of products thereof | |
| CN104225426A (en) | Chinese medicine for treating cerebral arteriosclerosis and preparation method thereof | |
| CN103830436A (en) | Traditional Chinese medicine composition for treating hypertension and preparation method thereof | |
| CN103479835A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
| CN105381289A (en) | Pharmaceutical composition for treating abnormal menstruation | |
| CN102302733A (en) | Oral Chinese medicinal composition for treating ovarian cyst | |
| CN101391081A (en) | Medicine composition for treating qi and blood derangement of essential hypertension and preparation method thereof | |
| CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
| CN104606514A (en) | Traditional Chinese medicine composition for treating kidney deficiency type tinnitus | |
| CN110201056A (en) | A kind of Chinese medicine composition and its preparation, preparation method and application | |
| CN104042981A (en) | Medicament for treating postnatal constipation and preparation method thereof | |
| CN104524479B (en) | A kind of Chinese medicine composition for treating premenstrual syndrome and preparation method thereof | |
| CN105456924A (en) | Traditional Chinese medicine preparation containing Folium Artemisiae Argyi and having functions of promoting circulation and removing stasis and preparation method thereof | |
| CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
| CN104547709A (en) | Chinese medicinal composition for treating meniere disease as well as preparation method and application thereof | |
| CN104758674A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN103735879A (en) | Traditional Chinese medicine decoction for treating carotid artery plaque |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160309 |